Mapracorat, a selective glucocorticoid receptor agonist, causes apoptosis of eosinophils infiltrating the conjunctiva in late-phase experimental ocular allergy

References

• Leonardi A Motterle L Bortolotti M Allergy and the eye Clin Exp Immunol 2008 153 Suppl 1 17 21 18721324
   PubMed Web of Science ®Google Scholar
• Bielory BP O’Brien TP Bielory L Management of seasonal allergic conjunctivitis: guide to therapy Acta Ophthalmol 2012 90 399 407 22067457
   PubMed Web of Science ®Google Scholar
• Guglielmetti S Dart JK Calder V Atopic keratoconjunctivitis and atopic dermatitis Curr Opin Allergy Clin Immunol 2010 10 478 485 20720488
   PubMed Web of Science ®Google Scholar
• Irkec MT Bozkurt B Molecular immunology of allergic conjunctivitis Curr Opin Allergy Clin Immunol 2012 12 534 539 22885886
   PubMed Web of Science ®Google Scholar
• Chauhan S Leach CH Kunz S Bloom JW Miesfeld RL Glucocorticoid regulation of human eosinophil gene expression J Steroid Biochem Mol Biol 2003 84 441 452 12732289
   PubMed Web of Science ®Google Scholar
• Bielory BP Perez VL Bielory L Treatment of seasonal allergic conjunctivitis with ophthalmic corticosteroids: in search of the perfect ocular corticosteroids in the treatment of allergic conjunctivitis Curr Opin Allergy Clin Immunol 2010 10 469 477 20720489
   PubMed Web of Science ®Google Scholar
• De Bosscher K Haegeman G Elewaut D Targeting inflammation using selective glucocorticoid receptor modulators Curr Opin Pharmacol 2010 10 497 504 20493772
   PubMed Web of Science ®Google Scholar
• Ratman D Vanden Berghe W Dejager L How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering Mol Cell Endocrinol 2013 380 41 54 23267834
   PubMed Web of Science ®Google Scholar
• Newton R Holden NS Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor? Mol Pharmacol 2007 72 799 809 17622575
   PubMed Web of Science ®Google Scholar
• Clark AR Belvisi MG Maps and legends: the quest for dissociated ligands of the glucocorticoid receptor Pharmacol Ther 2012 134 54 67 22212616
   PubMed Web of Science ®Google Scholar
• Newton R Anti-inflammatory glucocorticoids: changing concepts Eur J Pharmacol 2014 724 231 236 23747654
   PubMed Web of Science ®Google Scholar
• De Bosscher K Selective glucocorticoid receptor modulators J Steroid Biochem Mol Biol 2010 120 96 104 20206690
   PubMed Web of Science ®Google Scholar
• Schäcke H Zollner TM Döcke WD Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases Br J Pharmacol 2009 158 1088 1103 19422381
   PubMed Web of Science ®Google Scholar
• Bodor N Buchwald P Corticosteroid design for the treatment of asthma: structural insights and the therapeutic potential of soft corticosteroids Curr Pharm Des 2006 12 25 3241 3260 17020532
   PubMed Web of Science ®Google Scholar
• Proksch JW Lowe ER Ward KW Ocular pharmacokinetics of mapracorat, a novel selective glucocorticoid receptor agonist, in rabbits and monkeys Drug Metab Dispos 2011 39 1181 1187 21441467
   PubMed Web of Science ®Google Scholar
• Shafiee A Bucolo C Budzynski E Ward KW López FJ In vivo ocular efficacy profile of mapracorat, a novel selective glucocorticoid receptor agonist, in rabbit models of ocular disease Invest Ophthalmol Vis Sci 2011 52 1422 1430 20881303
   PubMed Web of Science ®Google Scholar
• Pfeffer BA DeWitt CA Salvador-Silva M Cavet ME López FJ Ward KW Reduced myocilin expression in cultured monkey trabecular meshwork cells induced by a selective glucocorticoid receptor agonist: comparison with steroids Invest Ophthalmol Vis Sci 2010 51 437 446 19696178
   PubMed Web of Science ®Google Scholar
• Baiula M Spartà A Bedini A Eosinophil as a cellular target of the ocular anti-allergic action of mapracorat, a novel selective glucocorticoid receptor agonist Mol Vis 2011 17 3208 3223 22194647
   PubMed Web of Science ®Google Scholar
• Cavet ME Volhejn S Harrington KL Zhang JZ Anti-allergic effects of mapracorat, a novel selective glucocorticoid receptor agonist, in human conjunctival fibroblasts and epithelial cells Mol Vis 2013 19 1515 1525 23878502
   PubMed Web of Science ®Google Scholar
• Cavet ME Harrington KL Ward KW Zhang JZ Mapracorat, a novel selective glucocorticoid receptor agonist, inhibits hyperosmolar-induced cytokine release and MAPK pathways in human corneal epithelial cells Mol Vis 2010 16 1791 1800 20824100
   PubMed Web of Science ®Google Scholar
• Chambless SL Trocme S Developments in ocular allergy Curr Opin Allergy Clin Immunol 2004 4 431 434 15349044
   PubMed Web of Science ®Google Scholar
• Bisset LR Schmid-Grendelmeier P Chemokines and their receptors in the pathogenesis of allergic asthma: progress and perspective Curr Opin Pulm Med 2005 11 35 42 15591886
   PubMed Web of Science ®Google Scholar
• Abu El-Asrar AM Struyf S Al-Kharashi SA Missotten L Van Damme J Geboes K Chemokines in the limbal form of vernal keratoconjunctivitis Br J Ophthalmol 2000 84 1360 1366 11090473
   PubMed Web of Science ®Google Scholar
• Leonardi A Jose PJ Zhan H Calder VL Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis Ophthalmology 2003 110 487 492 12623809
   PubMed Web of Science ®Google Scholar
• Kvarnhammar AM Cardell LO Pattern-recognition receptors in human eosinophils Immunology 2012 136 1 11 20 22242941
   PubMed Web of Science ®Google Scholar
• Duffin R Leitch AE Fox S Haslett C Rossi AG Targeting granulocyte apoptosis: mechanisms, models, and therapies Immunol Rev 2010 236 28 40 20636806
   PubMed Web of Science ®Google Scholar
• McColl A Michlewska S Dransfield I Rossi AG Effects of glucocorticoids on apoptosis and clearance of apoptotic cells ScientificWorldJournal 2007 7 1165 1181 17704849
   PubMed Web of Science ®Google Scholar
• Druilhe A Létuvé S Pretolani M Glucocorticoid-induced apoptosis in human eosinophils: mechanisms of action Apoptosis 2003 8 481 495 12975579
   PubMed Web of Science ®Google Scholar
• Baiula M Bedini A Carbonari G Dattoli SD Spampinato S Therapeutic targeting of eosinophil adhesion and accumulation in allergic conjunctivitis Front Pharmacol 2012 3 203 23271999
   PubMed Web of Science ®Google Scholar
• Woolley KL Gibson PG Carty K Wilson AJ Twaddell SH Woolley MJ Eosinophil apoptosis and the resolution of airway inflammation in asthma Am J Respir Crit Care Med 1996 154 237 243 8680686
   PubMed Web of Science ®Google Scholar
• Uller L Emanuelsson CA Andersson M Erjefält JS Greiff L Persson CG Early phase resolution of mucosal eosinophilic inflammation in allergic rhinitis Respir Res 2010 11 54 20459697
   PubMed Web of Science ®Google Scholar
• Uller L Persson CG Erjefält JS Resolution of airway disease: removal of inflammatory cells through apoptosis, egression or both? Trends Pharmacol Sci 2006 27 461 466 16876880
   PubMed Web of Science ®Google Scholar
• Qasem AR Bucolo C Baiula M Contribution of alpha4beta1 integrin to the antiallergic effect of levocabastine Biochem Pharmacol 2008 76 751 762 18680729
   PubMed Web of Science ®Google Scholar
• Kato M Imoto K Miyake H Oda T Miyaji S Nakamura M Apafant, a potent platelet-activating factor antagonist, blocks eosinophil activation and is effective in the chronic phase of experimental allergic conjunctivitis in guinea pigs J Pharmacol Sci 2004 95 435 442 15286429
   PubMed Web of Science ®Google Scholar
• Walker RA Quantification of immunohistochemistry – issues concerning methods, utility and semiquantitative assessment I Histopathology 2006 49 406 410 16978204
   PubMed Web of Science ®Google Scholar
• Kelly MM King EM Rider CF Corticosteroid-induced gene expression in allergen-challenged asthmatic subjects taking inhaled budesonide Br J Pharmacol 2012 165 1737 1747 21827450
   PubMed Web of Science ®Google Scholar
• Gavrieli Y Sherman Y Ben-Sasson SA Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation J Cell Biol 1992 119 493 501 1400587
   PubMed Web of Science ®Google Scholar
• Uller L Andersson M Greiff L Persson CG Erjefält JS Occurrence of apoptosis, secondary necrosis, and cytolysis in eosinophilic nasal polyps Am J Respir Crit Care Med 2004 170 742 747 15229095
   PubMed Web of Science ®Google Scholar
• Uller L Lloyd CM Rydell-Törmänen K Persson CG Erjefält JS Effects of steroid treatment on lung CC chemokines, apoptosis and transepithelial cell clearance during development and resolution of allergic airway inflammation Clin Exp Allergy 2006 36 111 121 16393273
   PubMed Web of Science ®Google Scholar
• Kubo S Kobayashi M Masunaga Y Cytokine and chemokine expression in cigarette smoke-induced lung injury in guinea pigs Eur Respir J 2005 26 993 1001 16319327
   PubMed Web of Science ®Google Scholar
• Lacy HM Bowlin AK Hennings L Scurlock AM Nagarajan UM Rank RG Essential role for neutrophils in pathogenesis and adaptive immunity in Chlamydia caviae ocular infections Infect Immun 2011 79 1889 1897 21402767
   PubMed Web of Science ®Google Scholar
• Choi SH Bielory L Late-phase reaction in ocular allergy Curr Opin Allergy Clin Immunol 2008 8 438 444 18769198
   PubMed Web of Science ®Google Scholar
• Zhang JZ Cavet ME VanderMeid KR Salvador-Silva M López FJ Ward KW BOL-303242-X, a novel selective glucocorticoid receptor agonist, with full anti-inflammatory properties in human ocular cells Mol Vis 2009 15 2606 2616 20011631
   PubMed Web of Science ®Google Scholar
• Zhang X Moilanen E Kankaanranta H Enhancement of human eosinophil apoptosis by fluticasone propionate, budesonide, and beclomethasone Eur J Pharmacol 2000 406 325 332 11040338
   PubMed Web of Science ®Google Scholar
• Kawabori S Soda K Perdue MH Bienenstock J The dynamics of intestinal eosinophil depletion in rats treated with dexamethasone Lab Invest 1991 64 224 233 1997734
   PubMed Web of Science ®Google Scholar
• Uller L Persson CG Källström L Erjefält JS Lung tissue eosinophils may be cleared through luminal entry rather than apoptosis: effects of steroid treatment Am J Respir Crit Care Med 2001 164 1948 1956 11734451
   PubMed Web of Science ®Google Scholar
• Barnes PJ Glucocorticosteroids: current and future directions Br J Pharmacol 2011 163 29 43 21198556
   PubMed Web of Science ®Google Scholar
• Lu NZ Cidlowski JA Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes Mol Cell 2005 18 331 342 15866175
   PubMed Web of Science ®Google Scholar
• Lu NZ Collins JB Grissom SF Cidlowski JA Selective regulation of bone cell apoptosis by translational isoforms of the glucocorticoid receptor Mol Cell Biol 2007 27 7143 7160 17682054
   PubMed Web of Science ®Google Scholar
• Wu I Shin SC Cao Y Selective glucocorticoid receptor translational isoforms reveal glucocorticoid-induced apoptotic transcriptomes Cell Death Dis 2013 4 e453 23303127
   PubMed Web of Science ®Google Scholar
• Catley M Dissociated steroids ScientificWorldJournal 2007 7 421 430 17450306
   PubMed Web of Science ®Google Scholar
• Clark AR Anti-inflammatory functions of glucocorticoid-induced genes Mol Cell Endocrinol 2007 275 79 97 17561338
   PubMed Web of Science ®Google Scholar
• Bausch & Lomb Incorporated Mapracorat Ophthalmic Formulation in Subjects With Allergic Conjunctivitis Available from: http://www.clinicaltrials.gov/ct2/show/NCT01289431?term=mapracorat&rank=6. NLM identifier: NCT01289431 Accessed March 20, 2014
   Google Scholar
• Bausch & Lomb Incorporated Study to Assess the Safety and Efficacy of BOL-303242-X Ophthalmic Suspension in Dry Eye Syndrome Available from: http://www.clinicaltrials.gov/ct2/show/NCT01163643?term=nct01163643&rank=1. NLM identifier: NCT01163643 Accessed March 20, 2014
   Google Scholar
• Bausch & Lomb Incorporated Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery Available from: http://www.clinicaltrials.gov/ct2/show/NCT01591161?term=mapracorat&rank=3. NLM identifier: NCT01591161 Accessed March 20, 2014
   Google Scholar